Navigation Links
Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results
Date:11/9/2009

BEIJING, Nov. 9 /PRNewswire-Asia-FirstCall/ -- Yongye International, Inc. (Nasdaq: YONG), ("Yongye or "the Company") a leading manufacturer, developer and distributor of Shengmingsu brand plant and animal nutrient products in the People's Republic of China (PRC), today announced that it will conduct a conference call at 10:00 a.m. Eastern Time (11:00 p.m. Beijing Time) on Monday, November 16, 2009 to discuss results for the quarter ended September 30, 2009.

To participate in this live conference call, please dial (888) 419-5570 five to ten minutes prior to the scheduled conference call time. International callers should dial (617) 896-9871. The conference pass code is 120 619 18.

For those individuals who are unable to participate in the conference call, a replay will be available for fourteen days starting on November 16, at 12:00 p.m. Eastern Time. To access the replay, please dial (888) 286-8010. International callers should dial (617) 801-6888. The replay pass code is 402 454 82.

Interested parties may also listen to the live conference call via webcast and access the replay by visiting http://www.yongyeintl.com/webcast.html .

About Yongye International, Inc.

Yongye International, Inc., headquartered in Beijing, is engaged in the manufacturing, development, distribution and sales of Shengmingsu brand plant and animal nutrient products. The Company's patented and patent pending formulas and proprietary extraction processes allow it to create products that increase crop yields and improve the health of livestock. Its sole operating subsidiary, Inner Mongolia Yongye Nongfeng Biotechnology Co., Ltd., is headquartered in Beijing with administrative and sales offices located in Inner Mongolia, People's Republic of C
'/>"/>

SOURCE Yongye International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Yongye International Announces 2010-2012 Strategic Plan
2. Yongye International Announces Expansion of Research and Development Center
3. Yongye International Announces Branded Store Network Increases Over 40% to 5,000 Stores
4. Yongye Biotechnology International Receives License to Manufacture Products
5. Yongye Biotechnology International Raises $ 9.0 Million In Private Placement, Raises Guidance
6. Yongye Biotechnology Distributor has Record Breaking Single Store Sales Day
7. Yongye Biotechnology Announces Preliminary Results for its Fiscal Quarter Ended March 31, 2009
8. Yongye Biotechnology Appoints New Chief Financial Officer
9. Yongye Biotechnology Announces Preliminary Results for Fiscal Year 2008
10. Yongye Biotechnology to Host Virtual Retail Road Show to Provide Overview of the Company in English and Mandarin
11. Yongye Biotechnology International to Expand its Network of Branded Stores

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...portunity to take the lead in two small biotechnol...lencia (UV), working together with the IDICHUS Fou... Spanish biotechnology industry. Their conclusion ...lout than those in English-speaking countries. , ...een overlooked by the leading countries in this se...
(Date:11/20/2009)...e-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) tod...blic offering of 6,800,000 shares of its common st...The approximately $21 million of net proceeds, aft...sions, will be used for preclinical studies and cl...research and development programs, working capital...
(Date:11/20/2009)...ly announced that a free webinar, “Roller Co...cle Characterization”, will be presented on ...n of in situ particle characterization is demonstr... of roller compaction runs while varying raw mater... (PRWEB) November 20, 2009...
(Date:11/19/2009)...anish Prince Joachim inaugurated the DONG Energy a... Denmark, on Wednesday, November 18. The facility ...tion ethanol demonstration biorefineries. Genencor...ovative process for converting straw to fuel. Gene...et with commercial enzymes for converting cellulos...
Breaking Biology Technology:Spanish biotechnology should focus on food and plant sectors to be more competitive 2Novavax Prices Public Offering of Common Stock 2Roller Compaction Process Optimization Using At-Line Particle Characterization 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2
...arma, a leading provider of,knowledge management s...nounced the release today of the new software solu...hers to rapidly evaluate target, cell and,drug pro...ata found in,Aureus Pharma,s AurSCOPE Target Knowl...ork in conjunction with the just released AurSCOPE...
...ua-PRNewswire/ -- WuXi AppTec, Inc., the,operating...S., has announced,the appointments of Garry Takle,...Hughes, Ph.D. as Vice President of Testing Service...www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ...ears in roles of,increasing responsibility at the ...
... The U.S. hospital,marketplace is multifaceted and...this challenging marketplace, pharmaceutical and b...gly complex organizational and,decision-making str...pital,formulary decisions are not only being influ... and safety but also by administrative personnel f...
Other Biology Technology:Aureus Pharma Releases AurPROFILER(R) - a New and Powerful Pharmacology Profiling Solution 2WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility 2U.S. Hospital Sales Opportunities Maximized Through Functional Optimization 2
(Date:11/20/2009)...blished in the November 2009 issue of the journal ... show how a family of genes (1-aminocyclopropane-1...le for production of ethylene. This gas affects ma...ion lays the foundation for future genetic manipul...le to survive and thrive in difficult terrain, inc...
(Date:11/20/2009)...asurements of plasma lipoprotein concentrations de...y (NMR), researchers led by Daniel Chasman at Brig...l in Boston, MA, the Framingham Heart Study in Fra..., Sweden and Oxford, England performed genetic ass...,296 women of European ancestry from the Women,s G...
(Date:11/20/2009)... to contribute their abstracts to the World Congre...rgest global meeting devoted to all aspects of ost...care. The Congress will be held in Florence, Italy...s can be submitted online at http://www.iofwco-ec...y 4, 2010. , IOF and ESCEO are pleased to announ...
Breaking Biology News(10 mins):It's a gas: New discovery may lead to heartier, high-yielding plants 2Genetic analysis helps dissect molecular basis of cardiovascular disease 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3Gen Probe Reports Financial Results for Second Quarter 2009 53283 1Gen Probe Reports Financial Results for Second Quarter 2009 53283 2Gen Probe Reports Financial Results for Second Quarter 2009 53283 3Gen Probe Reports Financial Results for Second Quarter 2009 53283 4Gen Probe Reports Financial Results for Second Quarter 2009 53283 5Gen Probe Reports Financial Results for Second Quarter 2009 53283 6Gen Probe Reports Financial Results for Second Quarter 2009 53283 7Gen Probe Reports Financial Results for Second Quarter 2009 53283 8Gen Probe Reports Financial Results for Second Quarter 2009 53283 9Gen Probe Reports Financial Results for Second Quarter 2009 53283 10Gen Probe Reports Financial Results for Second Quarter 2009 53283 11Gen Probe Reports Financial Results for Second Quarter 2009 53283 12Gen Probe Reports Financial Results for Second Quarter 2009 53283 13Gen Probe Reports Financial Results for Second Quarter 2009 53283 14Gen Probe Reports Financial Results for Second Quarter 2009 53283 15Gen Probe Reports Financial Results for Second Quarter 2009 53283 16Gen Probe Reports Financial Results for Second Quarter 2009 53283 17Gen Probe Reports Financial Results for Second Quarter 2009 53283 18Gen Probe Reports Financial Results for Second Quarter 2009 53283 19Gen Probe Reports Financial Results for Second Quarter 2009 53283 20Gen Probe Reports Financial Results for Second Quarter 2009 53283 21Gen Probe Reports Financial Results for Second Quarter 2009 53283 22WellPoint Announces Decision to Cover H1N1 Vaccine Administration 53281 1WellPoint Announces Decision to Cover H1N1 Vaccine Administration 53281 2Patents Issued Covering Stable Tablet Formulation and Once Daily Dosing Regimen for Kuvan 53278 1Patents Issued Covering Stable Tablet Formulation and Once Daily Dosing Regimen for Kuvan 53278 2Patents Issued Covering Stable Tablet Formulation and Once Daily Dosing Regimen for Kuvan 53278 3
...the first inherited gene mutation that increases a...LL), one of the most common forms of the disease. ...atly reduces the gene,s protective activity. Furth...turns the gene off altogether, leading to leukemia... is not inherited. , The findings could help i...
...y not be so bad after all when it comes to Alzheim...l of Clinical Investigation, a team of scientists ...ows that a key inflammatory regulator, a known vil...troke and other brain injuries, seems to do the op...n and helping get rid of clumps of material known ...
...ltural soils to reduce greenhouse gases and increa... by new research findings at NSW Department of Pri...titute. , Trials of agrichar - a product hailed as...d the environment - have doubled and, in one case,...0 tonnes per hectare. , Agrichar is a black car...
Other Biology News:Researchers discover inherited mutation for leukemia 2Researchers discover inherited mutation for leukemia 3Brain inflammation may be friend, not foe, for Alzheimer's patients 2Brain inflammation may be friend, not foe, for Alzheimer's patients 3Brain inflammation may be friend, not foe, for Alzheimer's patients 4Soils offer new hope as carbon sink 2Soils offer new hope as carbon sink 3
MetaMorph from Universal Imaging Corporation (a subsidiary of Molecular Devices)
PRO S-7C Stirrer, Ceramic Top, 115 V from PRO Scientific
Agencourt AMPure 60ml Kit from Agencourt Bioscience
EasySep Mouse Combo Starter, Kit from StemCell Technologies, Inc.
Biology Products: